The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 25, 2014
Filed:
Jun. 12, 2013
Applicant:
Isis Pharmaceuticals, Inc., Carlsbad, CA (US);
Inventors:
Sanjay Bhanot, Carlsbad, CA (US);
Xing-Xian Yu, San Diego, CA (US);
Susan M. Freier, San Diego, CA (US);
Ravi Jain, Fremont, CA (US);
Assignee:
Isis Pharmaceuticals, Inc., Carlsbad, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); A61K 45/06 (2006.01); A61K 31/7105 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1138 (2013.01); C12N 2310/315 (2013.01); C12N 2310/321 (2013.01); C12N 2310/11 (2013.01); C12N 2310/341 (2013.01); C12N 2310/346 (2013.01); C12N 2310/3341 (2013.01); A61K 45/06 (2013.01); A61K 31/7105 (2013.01);
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of fibroblast growth factor receptor 4 (FGFR4). The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding fibroblast growth factor receptor 4. Methods of using these compounds for modulation of fibroblast growth factor receptor 4 expression and for treatment of diseases associated with expression of fibroblast growth factor receptor 4 are provided.